BioNTech SE (BNTX)
99.70
+2.97 (3.07%)
Upcoming Events
Latest Headlines
Form 6-K BioNTech SE For: Sep 14
September 14, 2026 8:29 AM - SEC Filing
BioNTech drug shows doubled survival in lung cancer trial
September 14, 2026 4:27 AM - StreetInsider
BioNTech and OncoC4 Present Updated Data Showing Gotistobart Nearly Doubled Median Overall Survival versus Standard-of-Care Chemotherapy in Previously Treated Squamous Non-Small Cell Lung Cancer Patie
September 14, 2026 4:00 AM - StreetInsider
Form 4 BioNTech SE For: Sep 10 Filed by: Sahin Ugur
September 11, 2026 5:18 PM - SEC Filing
BMO lowers Amgen, BioNTech to Market Perform as risk-reward shifts
September 8, 2026 7:22 AM - StreetInsider
BMO Capital Downgrades BioNTech (BNTX) to Market Perform
September 8, 2026 4:36 AM - StreetInsider
BioNTech (BNTX) PT Lowered to $136 at Canaccord
August 31, 2026 7:08 AM - StreetInsider
BioNTech drops 10% on mRNA trial failure, highlighting Moderna contrast
August 28, 2026 9:46 AM - StreetInsider
BioNTech ends colorectal cancer mRNA therapy trial early
August 28, 2026 9:09 AM - StreetInsider
Form 6-K BioNTech SE For: Aug 28
August 28, 2026 9:06 AM - SEC Filing
Form 6-K BioNTech SE For: Aug 27
August 27, 2026 4:55 PM - SEC Filing
FDA approves Pfizer-BioNTech XFG-targeted Covid-19 vaccine
August 27, 2026 4:30 PM - StreetInsider
Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine
August 27, 2026 4:30 PM - Globe NewsWire
A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
August 26, 2026 9:20 AM - StreetInsider
Form 6-K BioNTech SE For: Aug 20
August 20, 2026 7:37 AM - SEC Filing
These 25 S&P 500 stocks saw the largest increase in institutional ownership in Q2
August 20, 2026 7:23 AM - StreetInsider
BioNTech SE (BNTX) Misses Q2 EPS by 18c
August 5, 2026 8:52 AM - StreetInsider
Form 6-K BioNTech SE For: Jun 30
August 4, 2026 7:02 AM - SEC Filing
Form 6-K BioNTech SE For: Aug 04
August 4, 2026 7:00 AM - SEC Filing
Form 6-K BioNTech SE For: Aug 03
August 3, 2026 6:54 AM - SEC Filing
Form 20-F/A BioNTech SE For: Dec 31
July 30, 2026 4:23 PM - SEC Filing
Form 6-K BioNTech SE For: Jul 29
July 29, 2026 5:08 PM - SEC Filing
BioNTech (BNTX) PT Lowered to $119 at Morgan Stanley
July 8, 2026 8:07 AM - StreetInsider
Form 3 BioNTech SE For: Jun 26 Filed by: Low-Friedrich Iris Katharina
June 26, 2026 9:11 AM - SEC Filing
Form 3 BioNTech SE For: Jun 26 Filed by: Schaffert Susanne
June 26, 2026 9:09 AM - SEC Filing
The New War on Cancer: Four Public Companies Helping Lead a Medical Revolution
June 25, 2026 11:40 AM - StreetInsider
Full Article List
